NEW YORK – Researchers at Children's Hospital of Philadelphia and Al Jalila Children's Specialty Hospital in Dubai have found that RNA sequencing in a cell line derived from blood can identify pathogenic variants in patients with neurodevelopmental disorders that were missed by DNA testing.
The approach, which the researchers plan to develop into a clinical test, could complement diagnostic exome or genome sequencing.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
